Staurosporine, a potent PKC inhibitor, controls cell adhesion, mobility, and invasion of A549 cells [10]; IL1-beta induces the expression of urokinase plasminogen activator (uPA) via PKCα, which leads to the migration of A549 NSCLC cells [11]. The gene discussed is PRKCA; the disease is non-small cell lung carcinoma.